p38δ MAPK: A Novel Regulator of NLRP3 Inflammasome Activation With Increased Expression in Coronary Atherogenesis.
about
Anti-inflammatory drugs as promising cardiovascular treatments.Cell Death in the Vessel Wall: The Good, the Bad, the Ugly.NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy.Asiatic acid protects against hepatic ischemia/reperfusion injury by inactivation of Kupffer cells via PPARγ/NLRP3 inflammasome signaling pathway.Gout and the risk of myocardial infarction in older adults: a study of Medicare recipients.
P2860
p38δ MAPK: A Novel Regulator of NLRP3 Inflammasome Activation With Increased Expression in Coronary Atherogenesis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
p38δ MAPK: A Novel Regulator o ...... ion in Coronary Atherogenesis.
@en
p38δ MAPK: A Novel Regulator o ...... ion in Coronary Atherogenesis.
@nl
type
label
p38δ MAPK: A Novel Regulator o ...... ion in Coronary Atherogenesis.
@en
p38δ MAPK: A Novel Regulator o ...... ion in Coronary Atherogenesis.
@nl
prefLabel
p38δ MAPK: A Novel Regulator o ...... ion in Coronary Atherogenesis.
@en
p38δ MAPK: A Novel Regulator o ...... ion in Coronary Atherogenesis.
@nl
P2093
P50
P1476
p38δ MAPK: A Novel Regulator o ...... sion in Coronary Atherogenesis
@en
P2093
Ana Cuenda
Jarno Tuimala
Kari K Eklund
Petri T Kovanen
P304
P356
10.1161/ATVBAHA.115.307312
P407
P577
2016-07-14T00:00:00Z